NCT03616847

Brief Summary

Patients listed for hallux valgus/hallux rigidus correction surgery will be randomised to one of two treatment groups. Group 1 (standard care) will have the calf tourniquet released after wound closure. Group 2 will have the tourniquet removed five minutes before wound closure. Participants will have the volume of their operated foot measured pre-operatively and post-operatively at six weeks and three months.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 6, 2018

Completed
17 days until next milestone

Study Start

First participant enrolled

August 23, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 26, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2021

Completed
Last Updated

May 24, 2019

Status Verified

May 1, 2019

Enrollment Period

3 years

First QC Date

July 25, 2018

Last Update Submit

May 22, 2019

Conditions

Keywords

Randomised controlled trialHallux valgus correctionHallux rigidus correctionTourniquetFoot volume

Outcome Measures

Primary Outcomes (1)

  • Foot volume

    The volume of the operated foot measured by water displacement (in millilitres).

    3 months post-operatively

Secondary Outcomes (3)

  • MOxFQ score

    3 months post-operatively

  • Foot pain assessed using a dolometer

    3 months post-operatively

  • Return to work

    3 months post-operatively

Study Arms (2)

Standard care

EXPERIMENTAL

Participants will have hallux valgus/hallux rigidus surgery using a calf tourniquet which will remain inflated until the wound is closed.

Other: Standard care

Tourniquet release

EXPERIMENTAL

Participants will have hallux valgus/hallux rigidus surgery using a calf tourniquet which will be removed. There will be a five minute delay before the wound is closed.

Other: Tourniquet release

Interventions

Hallux valgus/hallux rigidus surgery with the calf tourniquet remaining in situ until the wound is closed.

Standard care

Hallux valgus/hallux rigidus surgery with the calf tourniquet released five minutes before the wound is closed.

Tourniquet release

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients having hallux valgus or hallux rigidus
  • Able to give informed consent
  • Able to return for follow-up

You may not qualify if:

  • Patients with symptomatic peripheral vascular disease
  • Patients with known peripheral oedema from any cause
  • Patients who will also require lesser toe correction as part of the procedure
  • Active smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Golden Jubilee National Hospital

Clydebank, West Dunbartonshire, G81 4DY, United Kingdom

RECRUITING

MeSH Terms

Conditions

Hallux ValgusHallux Rigidus

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Foot DeformitiesMusculoskeletal DiseasesFoot Deformities, AcquiredJoint Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Kalpesh Shah, M.D.

    Gloden Jubilee National Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alistair M Ewen, Ph. D.

CONTACT

Kathryn Macpherson, B. Sc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Those collecting and analysis the data will be masked to the treatment groups. It is not possible to mask the participant or the care provider in this study
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two randomised study groups with one having standard care and the other the intervention.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2018

First Posted

August 6, 2018

Study Start

August 23, 2018

Primary Completion

August 26, 2021

Study Completion

November 25, 2021

Last Updated

May 24, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

No data will be shared

Locations